Owners, management and financials
CVR: 45161641
DKK -14,150,019
Gross profit
Net result: DKK -11,245,984
Thomas Koed Doktor (5-9,99%), Brage Storstein Andresen (10-14,99%)
2 more
CVR · view owners
Poul Sørensen
Board: Poul Sørensen (chair) and 3 members
CVR · view management
Active
Founded 22 October 2024
CVR · view overview
1 employee
Annual report 2025 · average
Owner registered: Thomas Koed Doktor
CVR · 01/12/2025
View the full event history
Inverna Therapeutics ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Poul Sørensen. The board consists of Poul Sørensen (chair), Brage Storstein Andresen, Daniel Sobral and Jens Kristian Damsgaard. The company's owners include Thomas Koed Doktor, Brage Storstein Andresen and SCIENCE VENTURES DENMARK A/S. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -14,150,019 and a net result of DKK -11,245,984. Equity in the 2025 report amounted to DKK 3,813,671.
Selskabets formål er research, udvikling og kommercialisering af farmaceutiske produkter og aktiviteter forbundet hermed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -14.2 mio. | -11.2 mio. | 6.9 mio. | 3.8 mio. | 1 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Inverna Therapeutics ApS is 45161641.
The owners of Inverna Therapeutics ApS include Thomas Koed Doktor, Brage Storstein Andresen and SCIENCE VENTURES DENMARK A/S.
The management of Inverna Therapeutics ApS consists of Poul Sørensen.
The board of Inverna Therapeutics ApS consists of Poul Sørensen, Brage Storstein Andresen and Daniel Sobral, with Poul Sørensen as chair.
In 2025, Inverna Therapeutics ApS reported a gross profit of DKK -14,150,019.
Inverna Therapeutics ApS had an average of 1 employee in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
Inverna Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -14,150,019, and the net result was DKK -11,245,984.
As of June 8, 2026, Jens Kristian Damsgaard has joined the board of directors of Inverna Therapeutics ApS.
As of June 8, 2026, Daniel Sobral has joined the board of directors of Inverna Therapeutics ApS.
As of June 8, 2026, Mads Aaboe Jensen has left the board of directors of Inverna Therapeutics ApS.
As of June 8, 2026, Pontus Fredrik Gunnar Klein has left the board of directors of Inverna Therapeutics ApS.
As of December 1, 2025, Thomas Koed Doktor is registered as an owner of Inverna Therapeutics ApS with an ownership share of 5%.
As of December 1, 2025, Brage Storstein Andresen is registered as an owner of Inverna Therapeutics ApS with an ownership share of 10%.
As of December 1, 2025, is registered as an owner of Inverna Therapeutics ApS with an ownership share of 50%.
Inverna Therapeutics ApS has published its interim report for the period October 22, 2024 – December 31, 2024.
As of December 20, 2024, SCIENCE VENTURES DENMARK A/S is registered as an owner of Inverna Therapeutics ApS with an ownership share of 5%.
As of October 22, 2024, Poul Sørensen has joined the board of directors of Inverna Therapeutics ApS.
As of October 22, 2024, Mads Aaboe Jensen has joined the board of directors of Inverna Therapeutics ApS.
As of October 22, 2024, Pontus Fredrik Gunnar Klein has joined the board of directors of Inverna Therapeutics ApS.
As of October 22, 2024, Brage Storstein Andresen has joined the board of directors of Inverna Therapeutics ApS.
As of October 22, 2024, Poul Sørensen is registered as director of Inverna Therapeutics ApS.
Inverna Therapeutics ApS was founded on October 22, 2024.
Companies in the same industry and area
CVR 26388899
CVR 40242244
CVR 36492449
CVR 44269422
CVR 40212744
